Dog Vaccines Industry Research Report 2025
Description
Summary
According to APO Research, the global Dog Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dog Vaccines include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dog Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dog Vaccines.
The report will help the Dog Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Dog Vaccines market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dog Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Dog Vaccines Segment by Company
Zoetis (Pfizer) Merck Animal Health Eli Lilly Bayer Healthcare Virbac Vetoquinol S.A Merial (Sanofi) Heska Co. Ceva Boehringer IngelheimDog Vaccines Segment by Type
Recombinant Vaccines Subunit Vaccines Inactivated Vaccines Toxoid Vaccines Attenuated Live Vaccines Conjugate Vaccines DNA VaccinesDog Vaccines Segment by Application
Below 6 Months Above MonthsDog Vaccines Segment by Region
North America United States Canada Europe Germany France U.K. Italy Netherlands Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dog Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dog Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Dog Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Dog Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dog Vaccines include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dog Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dog Vaccines.
The report will help the Dog Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Dog Vaccines market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dog Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Dog Vaccines Segment by Company
Zoetis (Pfizer) Merck Animal Health Eli Lilly Bayer Healthcare Virbac Vetoquinol S.A Merial (Sanofi) Heska Co. Ceva Boehringer IngelheimDog Vaccines Segment by Type
Recombinant Vaccines Subunit Vaccines Inactivated Vaccines Toxoid Vaccines Attenuated Live Vaccines Conjugate Vaccines DNA VaccinesDog Vaccines Segment by Application
Below 6 Months Above MonthsDog Vaccines Segment by Region
North America United States Canada Europe Germany France U.K. Italy Netherlands Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dog Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dog Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
125 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dog Vaccines Market Size (2020-2031)
- 2.2.2 Global Dog Vaccines Sales (2020-2031)
- 2.2.3 Global Dog Vaccines Market Average Price (2020-2031)
- 2.3 Dog Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Recombinant Vaccines
- 2.3.3 Subunit Vaccines
- 2.3.4 Inactivated Vaccines
- 2.3.5 Toxoid Vaccines
- 2.3.6 Attenuated Live Vaccines
- 2.3.7 Conjugate Vaccines
- 2.3.8 DNA Vaccines
- 2.4 Dog Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Below 6 Months
- 2.4.3 Above Months
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dog Vaccines Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Dog Vaccines Sales (k units) of Manufacturers (2020-2025)
- 3.3 Global Dog Vaccines Revenue of Manufacturers (2020-2025)
- 3.4 Global Dog Vaccines Average Price by Manufacturers (2020-2025)
- 3.5 Global Dog Vaccines Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Dog Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dog Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Dog Vaccines, Established Date
- 3.9 Global Dog Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Zoetis (Pfizer)
- 4.1.1 Zoetis (Pfizer) Company Information
- 4.1.2 Zoetis (Pfizer) Business Overview
- 4.1.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Zoetis (Pfizer) Dog Vaccines Product Portfolio
- 4.1.5 Zoetis (Pfizer) Recent Developments
- 4.2 Merck Animal Health
- 4.2.1 Merck Animal Health Company Information
- 4.2.2 Merck Animal Health Business Overview
- 4.2.3 Merck Animal Health Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Merck Animal Health Dog Vaccines Product Portfolio
- 4.2.5 Merck Animal Health Recent Developments
- 4.3 Eli Lilly
- 4.3.1 Eli Lilly Company Information
- 4.3.2 Eli Lilly Business Overview
- 4.3.3 Eli Lilly Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Eli Lilly Dog Vaccines Product Portfolio
- 4.3.5 Eli Lilly Recent Developments
- 4.4 Bayer Healthcare
- 4.4.1 Bayer Healthcare Company Information
- 4.4.2 Bayer Healthcare Business Overview
- 4.4.3 Bayer Healthcare Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Bayer Healthcare Dog Vaccines Product Portfolio
- 4.4.5 Bayer Healthcare Recent Developments
- 4.5 Virbac
- 4.5.1 Virbac Company Information
- 4.5.2 Virbac Business Overview
- 4.5.3 Virbac Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Virbac Dog Vaccines Product Portfolio
- 4.5.5 Virbac Recent Developments
- 4.6 Vetoquinol S.A
- 4.6.1 Vetoquinol S.A Company Information
- 4.6.2 Vetoquinol S.A Business Overview
- 4.6.3 Vetoquinol S.A Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Vetoquinol S.A Dog Vaccines Product Portfolio
- 4.6.5 Vetoquinol S.A Recent Developments
- 4.7 Merial (Sanofi)
- 4.7.1 Merial (Sanofi) Company Information
- 4.7.2 Merial (Sanofi) Business Overview
- 4.7.3 Merial (Sanofi) Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Merial (Sanofi) Dog Vaccines Product Portfolio
- 4.7.5 Merial (Sanofi) Recent Developments
- 4.8 Heska Co.
- 4.8.1 Heska Co. Company Information
- 4.8.2 Heska Co. Business Overview
- 4.8.3 Heska Co. Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Heska Co. Dog Vaccines Product Portfolio
- 4.8.5 Heska Co. Recent Developments
- 4.9 Ceva
- 4.9.1 Ceva Company Information
- 4.9.2 Ceva Business Overview
- 4.9.3 Ceva Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 Ceva Dog Vaccines Product Portfolio
- 4.9.5 Ceva Recent Developments
- 4.10 Boehringer Ingelheim
- 4.10.1 Boehringer Ingelheim Company Information
- 4.10.2 Boehringer Ingelheim Business Overview
- 4.10.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 Boehringer Ingelheim Dog Vaccines Product Portfolio
- 4.10.5 Boehringer Ingelheim Recent Developments
- 5 Global Dog Vaccines Market Scenario by Region
- 5.1 Global Dog Vaccines Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Dog Vaccines Sales by Region: 2020-2031
- 5.2.1 Global Dog Vaccines Sales by Region: 2020-2025
- 5.2.2 Global Dog Vaccines Sales by Region: 2026-2031
- 5.3 Global Dog Vaccines Revenue by Region: 2020-2031
- 5.3.1 Global Dog Vaccines Revenue by Region: 2020-2025
- 5.3.2 Global Dog Vaccines Revenue by Region: 2026-2031
- 5.4 North America Dog Vaccines Market Facts & Figures by Country
- 5.4.1 North America Dog Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Dog Vaccines Sales by Country (2020-2031)
- 5.4.3 North America Dog Vaccines Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Dog Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Dog Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Dog Vaccines Sales by Country (2020-2031)
- 5.5.3 Europe Dog Vaccines Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Dog Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dog Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Dog Vaccines Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Dog Vaccines Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dog Vaccines Market Facts & Figures by Country
- 5.7.1 South America Dog Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Dog Vaccines Sales by Country (2020-2031)
- 5.7.3 South America Dog Vaccines Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Dog Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dog Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Dog Vaccines Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Dog Vaccines Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Dog Vaccines Sales by Type (2020-2031)
- 6.1.1 Global Dog Vaccines Sales by Type (2020-2031) & (k units)
- 6.1.2 Global Dog Vaccines Sales Market Share by Type (2020-2031)
- 6.2 Global Dog Vaccines Revenue by Type (2020-2031)
- 6.2.1 Global Dog Vaccines Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Dog Vaccines Revenue Market Share by Type (2020-2031)
- 6.3 Global Dog Vaccines Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Dog Vaccines Sales by Application (2020-2031)
- 7.1.1 Global Dog Vaccines Sales by Application (2020-2031) & (k units)
- 7.1.2 Global Dog Vaccines Sales Market Share by Application (2020-2031)
- 7.2 Global Dog Vaccines Revenue by Application (2020-2031)
- 7.2.1 Global Dog Vaccines Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Dog Vaccines Revenue Market Share by Application (2020-2031)
- 7.3 Global Dog Vaccines Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dog Vaccines Value Chain Analysis
- 8.1.1 Dog Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dog Vaccines Production Mode & Process
- 8.2 Dog Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dog Vaccines Distributors
- 8.2.3 Dog Vaccines Customers
- 9 Global Dog Vaccines Analyzing Market Dynamics
- 9.1 Dog Vaccines Industry Trends
- 9.2 Dog Vaccines Industry Drivers
- 9.3 Dog Vaccines Industry Opportunities and Challenges
- 9.4 Dog Vaccines Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Dog Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Dog Vaccines Sales (k units) of Manufacturers (2020-2025)
- Table 7. Global Dog Vaccines Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Dog Vaccines Revenue of Manufacturers (2020-2025)
- Table 9. Global Dog Vaccines Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Dog Vaccines Average Price (US$/unit) of Manufacturers (2020-2025)
- Table 11. Global Dog Vaccines Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Dog Vaccines, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Dog Vaccines, Product Type & Application
- Table 14. Global Dog Vaccines Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Dog Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Zoetis (Pfizer) Company Information
- Table 19. Zoetis (Pfizer) Business Overview
- Table 20. Zoetis (Pfizer) Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 21. Zoetis (Pfizer) Dog Vaccines Product Portfolio
- Table 22. Zoetis (Pfizer) Recent Developments
- Table 23. Merck Animal Health Company Information
- Table 24. Merck Animal Health Business Overview
- Table 25. Merck Animal Health Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 26. Merck Animal Health Dog Vaccines Product Portfolio
- Table 27. Merck Animal Health Recent Developments
- Table 28. Eli Lilly Company Information
- Table 29. Eli Lilly Business Overview
- Table 30. Eli Lilly Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 31. Eli Lilly Dog Vaccines Product Portfolio
- Table 32. Eli Lilly Recent Developments
- Table 33. Bayer Healthcare Company Information
- Table 34. Bayer Healthcare Business Overview
- Table 35. Bayer Healthcare Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 36. Bayer Healthcare Dog Vaccines Product Portfolio
- Table 37. Bayer Healthcare Recent Developments
- Table 38. Virbac Company Information
- Table 39. Virbac Business Overview
- Table 40. Virbac Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 41. Virbac Dog Vaccines Product Portfolio
- Table 42. Virbac Recent Developments
- Table 43. Vetoquinol S.A Company Information
- Table 44. Vetoquinol S.A Business Overview
- Table 45. Vetoquinol S.A Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 46. Vetoquinol S.A Dog Vaccines Product Portfolio
- Table 47. Vetoquinol S.A Recent Developments
- Table 48. Merial (Sanofi) Company Information
- Table 49. Merial (Sanofi) Business Overview
- Table 50. Merial (Sanofi) Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 51. Merial (Sanofi) Dog Vaccines Product Portfolio
- Table 52. Merial (Sanofi) Recent Developments
- Table 53. Heska Co. Company Information
- Table 54. Heska Co. Business Overview
- Table 55. Heska Co. Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 56. Heska Co. Dog Vaccines Product Portfolio
- Table 57. Heska Co. Recent Developments
- Table 58. Ceva Company Information
- Table 59. Ceva Business Overview
- Table 60. Ceva Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 61. Ceva Dog Vaccines Product Portfolio
- Table 62. Ceva Recent Developments
- Table 63. Boehringer Ingelheim Company Information
- Table 64. Boehringer Ingelheim Business Overview
- Table 65. Boehringer Ingelheim Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 66. Boehringer Ingelheim Dog Vaccines Product Portfolio
- Table 67. Boehringer Ingelheim Recent Developments
- Table 68. Global Dog Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 69. Global Dog Vaccines Sales by Region (2020-2025) & (k units)
- Table 70. Global Dog Vaccines Sales Market Share by Region (2020-2025)
- Table 71. Global Dog Vaccines Sales by Region (2026-2031) & (k units)
- Table 72. Global Dog Vaccines Sales Market Share by Region (2026-2031)
- Table 73. Global Dog Vaccines Revenue by Region (2020-2025) & (US$ Million)
- Table 74. Global Dog Vaccines Revenue Market Share by Region (2020-2025)
- Table 75. Global Dog Vaccines Revenue by Region (2026-2031) & (US$ Million)
- Table 76. Global Dog Vaccines Revenue Market Share by Region (2026-2031)
- Table 77. North America Dog Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 78. North America Dog Vaccines Sales by Country (2020-2025) & (k units)
- Table 79. North America Dog Vaccines Sales by Country (2026-2031) & (k units)
- Table 80. North America Dog Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 81. North America Dog Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 82. Europe Dog Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 83. Europe Dog Vaccines Sales by Country (2020-2025) & (k units)
- Table 84. Europe Dog Vaccines Sales by Country (2026-2031) & (k units)
- Table 85. Europe Dog Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 86. Europe Dog Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 87. Asia Pacific Dog Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 88. Asia Pacific Dog Vaccines Sales by Country (2020-2025) & (k units)
- Table 89. Asia Pacific Dog Vaccines Sales by Country (2026-2031) & (k units)
- Table 90. Asia Pacific Dog Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 91. Asia Pacific Dog Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 92. South America Dog Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 93. South America Dog Vaccines Sales by Country (2020-2025) & (k units)
- Table 94. South America Dog Vaccines Sales by Country (2026-2031) & (k units)
- Table 95. South America Dog Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 96. South America Dog Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 97. Middle East and Africa Dog Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 98. Middle East and Africa Dog Vaccines Sales by Country (2020-2025) & (k units)
- Table 99. Middle East and Africa Dog Vaccines Sales by Country (2026-2031) & (k units)
- Table 100. Middle East and Africa Dog Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 101. Middle East and Africa Dog Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 102. Global Dog Vaccines Sales by Type (2020-2025) & (k units)
- Table 103. Global Dog Vaccines Sales by Type (2026-2031) & (k units)
- Table 104. Global Dog Vaccines Sales Market Share by Type (2020-2025)
- Table 105. Global Dog Vaccines Sales Market Share by Type (2026-2031)
- Table 106. Global Dog Vaccines Revenue by Type (2020-2025) & (US$ Million)
- Table 107. Global Dog Vaccines Revenue by Type (2026-2031) & (US$ Million)
- Table 108. Global Dog Vaccines Revenue Market Share by Type (2020-2025)
- Table 109. Global Dog Vaccines Revenue Market Share by Type (2026-2031)
- Table 110. Global Dog Vaccines Price by Type (2020-2025) & (US$/unit)
- Table 111. Global Dog Vaccines Price by Type (2026-2031) & (US$/unit)
- Table 112. Global Dog Vaccines Sales by Application (2020-2025) & (k units)
- Table 113. Global Dog Vaccines Sales by Application (2026-2031) & (k units)
- Table 114. Global Dog Vaccines Sales Market Share by Application (2020-2025)
- Table 115. Global Dog Vaccines Sales Market Share by Application (2026-2031)
- Table 116. Global Dog Vaccines Revenue by Application (2020-2025) & (US$ Million)
- Table 117. Global Dog Vaccines Revenue by Application (2026-2031) & (US$ Million)
- Table 118. Global Dog Vaccines Revenue Market Share by Application (2020-2025)
- Table 119. Global Dog Vaccines Revenue Market Share by Application (2026-2031)
- Table 120. Global Dog Vaccines Price by Application (2020-2025) & (US$/unit)
- Table 121. Global Dog Vaccines Price by Application (2026-2031) & (US$/unit)
- Table 122. Key Raw Materials
- Table 123. Raw Materials Key Suppliers
- Table 124. Dog Vaccines Distributors List
- Table 125. Dog Vaccines Customers List
- Table 126. Dog Vaccines Industry Trends
- Table 127. Dog Vaccines Industry Drivers
- Table 128. Dog Vaccines Industry Restraints
- Table 129. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Dog Vaccines Product Image
- Figure 5. Global Dog Vaccines Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Dog Vaccines Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Dog Vaccines Sales (2020-2031) & (k units)
- Figure 8. Global Dog Vaccines Average Price (US$/unit) & (2020-2031)
- Figure 9. Recombinant Vaccines Product Image
- Figure 10. Subunit Vaccines Product Image
- Figure 11. Inactivated Vaccines Product Image
- Figure 12. Toxoid Vaccines Product Image
- Figure 13. Attenuated Live Vaccines Product Image
- Figure 14. Conjugate Vaccines Product Image
- Figure 15. DNA Vaccines Product Image
- Figure 16. Below 6 Months Product Image
- Figure 17. Above Months Product Image
- Figure 18. Global Dog Vaccines Revenue Share by Manufacturers in 2024
- Figure 19. Global Manufacturers of Dog Vaccines, Manufacturing Sites & Headquarters
- Figure 20. Global Top 5 and 10 Dog Vaccines Players Market Share by Revenue in 2024
- Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 22. Global Dog Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 23. Global Dog Vaccines Sales by Region in 2024
- Figure 24. Global Dog Vaccines Revenue by Region in 2024
- Figure 25. North America Dog Vaccines Market Size by Country in 2024
- Figure 26. North America Dog Vaccines Sales Market Share by Country (2020-2031)
- Figure 27. North America Dog Vaccines Revenue Market Share by Country (2020-2031)
- Figure 28. United States Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 29. Canada Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 30. Europe Dog Vaccines Market Size by Country in 2024
- Figure 31. Europe Dog Vaccines Sales Market Share by Country (2020-2031)
- Figure 32. Europe Dog Vaccines Revenue Market Share by Country (2020-2031)
- Figure 33. Germany Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. France Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. U.K. Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Italy Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Netherlands Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 38. Asia Pacific Dog Vaccines Market Size by Country in 2024
- Figure 39. Asia Pacific Dog Vaccines Sales Market Share by Country (2020-2031)
- Figure 40. Asia Pacific Dog Vaccines Revenue Market Share by Country (2020-2031)
- Figure 41. China Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 42. Japan Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 43. South Korea Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. India Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. Australia Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. China Taiwan Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. Southeast Asia Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. Southeast Asia Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 49. South America Dog Vaccines Market Size by Country in 2024
- Figure 50. South America Dog Vaccines Sales Market Share by Country (2020-2031)
- Figure 51. South America Dog Vaccines Revenue Market Share by Country (2020-2031)
- Figure 52. Mexico Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 53. Brazil Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 54. Argentina Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 55. Middle East and Africa Dog Vaccines Market Size by Country in 2024
- Figure 56. Middle East and Africa Dog Vaccines Sales Market Share by Country (2020-2031)
- Figure 57. Middle East and Africa Dog Vaccines Revenue Market Share by Country (2020-2031)
- Figure 58. Turkey Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 59. Saudi Arabia Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 60. UAE Dog Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 61. Global Dog Vaccines Sales Market Share by Type (2020-2031)
- Figure 62. Global Dog Vaccines Revenue Market Share by Type (2020-2031)
- Figure 63. Global Dog Vaccines Price (US$/unit) by Type (2020-2031)
- Figure 64. Global Dog Vaccines Sales Market Share by Application (2020-2031)
- Figure 65. Global Dog Vaccines Revenue Market Share by Application (2020-2031)
- Figure 66. Global Dog Vaccines Price (US$/unit) by Application (2020-2031)
- Figure 67. Dog Vaccines Value Chain
- Figure 68. Dog Vaccines Production Mode & Process
- Figure 69. Direct Comparison with Distribution Share
- Figure 70. Distributors Profiles
- Figure 71. Dog Vaccines Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



